Skip to main content
. 2010 Oct;31(10):E1709–E1766. doi: 10.1002/humu.21336

Table 1.

Mutations identified in 80 unrelated patients with LCA/EORD, using LCA chip analysis and direct sequencing of CEP290, CRB1, RPE65, AIPL1, GUCY2D and CRX

Allele 1 Allele 2 Reference


Patient Origin Par cons Segr Intron/exon Nucleotide change Amino acid change Intron/exon Nucleotide change Amino acid change
CEP290

LCA-1 Belgium - X I26 c.2991+1655A>G* p.Cys998X* I26 c.2991+1655A>G* p.Cys998X* (den Hollander et al., 2006)

LCA-2 Belgium - X I26 c.2991+1655A>G p.Cys998X I26 c.2991+1655A>G p.Cys998X (den Hollander et al., 2006)

LCA-3+ Belgium - X I26 c.2991+1655A>G* p.Cys998X* E6 c.322C>T p.Arg108X (den Hollander et al., 2006)

LCA-4 Belgium - NA I26 c.2991+1655A>G p.Cys998X E25 c.2695C>T p.Gln899X (den Hollander et al., 2006)

LCA-5 Belgium - NA I26 c.2991+1655A>G p.Cys998X E34 c.4393C>T p.Arg1465X (den Hollander et al., 2006), (Brancati et al., 2007) (CORS)

LCA-6 Belgium - X I26 c.2991+1655A>G p.Cys998X E36 c.4723A>T p.Lys1575X (den Hollander et al., 2006), (Brancati et al., 2007; Perrault et al., 2007)

LCA-7F Belgium - NA I26 c.2991+1655A>G p.Cys998X E36 c.4723A>T p.Lys1575X (den Hollander et al., 2006), (Brancati et al., 2007; Perrault et al., 2007)

LCA-8 Belgium - NA I26 c.2991+1655A>G p.Cys998X E36 c.4723A>T p.Lys1575X (den Hollander et al., 2006), (Brancati et al., 2007; Perrault et al., 2007)

LCA-9 Belgium - X I26 c.2991+1655A>G p.Cys998X E39 c.5344C>T p.Arg1782X (den Hollander et al., 2006)

LCA-10 Lithuania - X I26 c.2991+1655A>G p.Cys998X E6 c.384 385del p.Asp128GlufsX17 (den Hollander et al., 2006)

LCA-11 Belgium - X I26 c.2991+1655A>G p.Cys998X E6 c.437del p.Glu146GlyfsX17 (den Hollander et al., 2006)

LCA-12 The Netherlands - NA 126 c.2991+1655A>G* p.Cys998X* E19 c.1859_1862del p.Arg621IlefsX2 (den Hollander et al., 2006), (Perrault et al., 2007)

LCA-13 Belgium - NA I26 c.2991+1655A>G p.Cys998X E29 c.3422dup p.Leu1141PhefsX5 (den Hollander et al., 2006)

LCA-14 Belgium/Morocco - X I26 c.2991+1655A>G* p.Cys998X* E31 c.4001del p.Thr1334IlefsX2 (den Hollander et al., 2006)

LCA-15 (Perrault et al., 2007) Belgium - NA I26 c.2991+1655A>G p.Cys998X E37 c.4962_4963del p.Glu1656AsnfsX3 (den Hollander et al., 2006), (Perrault et al., 2007)

LCA-16+ Belgium/Greece - X I26 c.2991+1655A>G p.Cys998X E40 c.5493del p.Ala1832ProfsX19 (den Hollander et al., 2006), (Brancati et al., 2007; Frank et al., 2008) (CORS)

LCA-17 Belgium - X I26 c.2991+1655A>G p.Cys998X E40 c.5519 5537del p.Lys1840ArgfsX5 (den Hollander et al., 2006)

LCA-18 Belgium - X I26 c.2991+1655A>G p.Cys998X E43 c.5865 5867delins GG p.Glu1956GlyfsX9 (den Hollander et al., 2006)

LCA-19 Belgium - X I26 c.2991+1655A>G p.Cys998X I13 c.1189+1G>A Splice defect (den Hollander et al., 2006)

LCA-20+ (Yzer et al., 2006) Belgium - NA I26 c.2991+1655A>G p.Cys998X 121 c.2218-2A>C Splice defect (den Hollander et al., 2006)

LCA-21 Belgium - X I26 c.2991+1655A>G p.Cys998X I28-E29 c.3310-1 3310delinsAA Splice defect (den Hollander et al., 2006)

LCA-22 Belgium - NA I26 c.2991+1655A>G p.Cys998X I28-E29 c.3310-1 3310delinsAA Splice defect (den Hollander et al., 2006)

LCA-23 Belgium - NA I26 c.2991+1655A>G p.Cys998X I28-E29 c.3310-1 3310delinsAA Splice defect (den Hollander et al., 2006)

LCA-24 Belgium - NA E36 c.4723A>T p.Lys1575X E36 c.4723A>T p.Lys1575X (Perrault et al., 2007)

LCA-25F Belgium - X E36 c.4723A>T p.Lys1575X E35 c.4696G>C p.Ala1566Pro UV (Perrault et al., 2007)

LCA-26 Belgium X E18 c.1824G>A p.=, splice site E38 c.5081T>C p.Leu1694Pro UV

LCA-27 Belgium - NA I26 c.2991+1655A>G p.Cys998X ? ? ? (den Hollander et al., 2006)

SLS-1 Pakistan FC X E2 c.21G>T p.Trp7Cys E2 c.21G>T p.Trp7Cys (Valente et al., 2006b) (CORS)

SLS-2 Belgium - NA E36 c.4723A>T p.Lys1575X E34 c.4393C>T p.Arg1465X (Perrault et al., 2007), (Brancati et al., 2007) (CORS)

SLS-3 Belgium - NA E36 c.4723A>T p.Lys1575X E34 c.4393C>T p.Arg1465X (Perrault et al., 2007), (Brancati et al., 2007) (CORS)

CORS-1+ (Brancati et al., 2007) Belgium SD NA E36 c.4723A>T p.Lys1575X E34 c.4393C>T p.Arg1465X (Perrault et al., 2007), (Brancati et al., 2007) (CORS)

LCA-JS-1 Belgium - X I40 c.5587-1G>C Splice defect E31 c.3793C>T p.Gln1265X (Perrault 2007), (Baala et al., 2007) (ML)

LCA-JS-2 II-1 E54 c.7366 7369del p.Thr2457AlafsX27 E54 c.7366 7369del p.Thr2457AlafsX27


LCA-JS-2 II-2 ND + X E54 c.7366 7369del p.Thr2457AlafsX27 E54 c.7366 7369del p.Thr2457AlafsX27

LCA-JS-3 Belgium - NA I28-E29 c.3310-1 3310delinsAA Splice defect E54 c.7341dup p.Leu2448ThrfsX8 (Sayer et al., 2006)

CRB1

LCA-28 Belgium - NA E7 c.2401A>T* p.Lys801X* E7 c.2401A>T* p.Lys801X* (den Hollander et al., 2001)

LCA-29 (Yzer et al., 2006) Belgium - NA E7 c.2401A>T* p.Lys801X* E5 c.1084C>T p.Gln362X (den Hollander et al., 2001), (Yzer et al., 2006)

LCA-30 Belgium - X E7 c.2401A>T* p.Lys801X* E7 c.2290C>T* p.Arg764Cys* (den Hollander et al., 2001), (Lotery et al., 2001)

LCA-31 (Yzer et al., 2006) Belgium - X E7 c.2401A>T* p.Lys801X* E8 c.2688T>A* p.Cys896X* (den Hollander et al., 2001), (Hanein et al., 2004)

LCA-32 (Yzer et al., 2006) Belgium - NA E7 c.2401A>T* p.Lys801X* E8 c.2688T>A* p.Cys896X* (den Hollander et al., 2001), (Hanein et al., 2004)

LCA-33 Belgium - NA E7 c.2401A>T* p.Lys801X* E9 c.2843G>A* p.Cys948Tyr* (den Hollander et al., 2001), (Lotery et al., 2001)

LCA-34 Belgium - X E7 c.2401A>T* p.Lys801X* I11 c.4006-1G>T Splice defect (den Hollander et al., 2001)

LCA-35 Belgium + NA E9 c.2843G>A* p.Cys948Tyr* E9 c.2843G>A* p.Cys948Tyr* (Lotery et al., 2001)

LCA-36 ND - NA E9 c.2843G>A* p.Cys948Tyr* Ell c.3988G>T* p.Glu1330X* (Lotery et al., 2001), (LCA chip)

LCA-37 Belgium - X E9 c.2843G>A* p.Cys948Tyr* I8 c.2842+5G>A* Splice defect* (Lotery et al., 2001), (den Hollander et al., 1999)

LCA-38 Belgium - X E9 c.2843G>A* p.Cys948Tyr* I8 c.2842+5G>A* Splice defect* (Lotery et al., 2001), (den Hollander et al., 1999)

LCA-39a E9 c.2843G>A* p.Cys948Tyr* I8 c.2842+5G+A* Splice defect* (Lotery et al., 2001), (den Hollander et al., 1999)


LCA-39b Belgium - X I11 c.4005+1G>A Splice defect I8 c.2842+5G>A Splice defect (Hanein et al., 2004), (den Hollander et al., 1999)

LCA-40 Belgium - NA I11 c.4005+1G>A* Splice defect* I8 c.2842+5G>A* Splice defect* (Hanein et al., 2004), (den Hollander et al., 1999)

LCA-41 II-1 E7 c.2441 2442del p.Leu814ArgfsX23 E9 c.3713 3716dup p.Cys1240ProfsX24


LCA-41 II-2 E7 c.2441 2442del p.Leu814ArgfsX23 E9 c.3713 3716dup p.Cys1240ProfsX24

LCA-42 ND + NA E11 c.3879G>A* p.Trp1293X* E11 c.3879G>A* p.Trp1293X* (Hanein et al., 2004)

EORD-1 II-1 E9 c.2843G>A* p.Cys948Tyr* E7 c.2401A>T* p.Lys801X* (Lotery et al., 2001), (den Hollander et al., 2001)


EORD-1 II-2 Belgium - X E9 c.2843G>A p.Cys948Tyr E7 c.2401A>T p.Lys801X (Lotery et al., 2001), (den Hollander et al., 2001)

EORD-2 Belgium NA E9 c.2843G>A p.Cys948Tyr E4 c.929G>A p.Cys310Tyr (Lotery et al., 2001)

EORD-3 Belgium - X E9 c.2843G>A* p.Cys948Tyr* E6 c.1472A>T p.Asp491Val UV (Lotery et al., 2001)

EORD-4 Belgium NA E5 c.1084C>T* p.Gln362X* E5 c.1084C>T* p.Gln362X* (Yzer et al., 2006)

EORD-5 Belgium - NA E7 c.2290C>T* p.Arg764Cys* E7 c.2290C>T* p.Arg764Cys* (Lotery et al., 2001)

RPE65

LCA-43 Turkey FC X E3 c.131G>A* p.Arg44Gln* E3 c.131G>A* p.Arg44Gln* (Simovich et al., 2001)

LCA-44 Turkey FC X E6 c.542C>T p.Pro181Leu E6 c.542C>T p.Pro181Leu

LCA-45a E7 c.700C>T* p.Arg234X* E9 c.991 993dup p.Trp331dup (Marlhens et al., 1997)


LCA-45b E9 c.991 993dup p.Trp331dup E9 c.991 993dup p.Trp331dup

LCA-46 Portugal X (c.10 22T> C) E10 c.1022T>C* p.Leu341Ser* E5 c.361delT p.Ser121LeufsX6 de novo (Morimura et al., 1998) (ARRP)

LCA-47 Belgium - X E14 c.1590del* p.Phe530LeufsX40* E14 c.1590del* p.Phe530LeufsX40* (Yzer et al., 2006)

LCA-48 Belgium - X E14 c.1590del p.Phe530LeufsX40 E5 c.370C>T* p.Arg124X* (Yzer et al., 2006), (Morimura et al., 1998)

LCA-49 Belgium - X E14 c.1590del* p.Phe530LeufsX40* 11 c.11+5G>A* Splice defect* (Yzer et al., 2006), (Gu et al., 1997)

LCA-50 Belgium/Russia (mother) - X E9 c.886dupA p.Arg296LysfsX7 11 c.11+5G>A* Splice defect* (Gu et al., 1997)

GUCY2D

LCA-51 Morocco/Belgium - NA E2 c.389del p.Pro130LeufsX36 I13 c.2577-2A>C Splice defect (Perrault et al., 1996)

LCA-52 Turkey TC NA E8 c.1694T>C* p.Phe565Ser* E8 c.1694T>C* p.Phe565Ser* (Perrault et al., 1996)

LCA-53 Belgium NA E12 c.2302C>T* p.Arg768Trp* E12 c.2302C>T* p.Arg768Trp* (Lotery et al., 2000)

LCA-54 Morocco/Belgium - X E12 c.2302C>T* p.Arg768Trp* E8 c.1694T>C* p.Phe565Ser* (Lotery et al., 2000), (Perrault et al., 1996)

LCA-55 Belgium - X E12 c.2302C>T* p.Arg768Trp* E14 c.2598G>C p.Lys866Asn (Lotery et al., 2000)

LCA-56 Belgium/France - X E2 c.587A>T p.Glu196Val UV Ell c.2132C>T p.Pro711Leu UV

LCA-57 Africa - NA E8 c.1724C>T* p.Pro575Leu* UV ? ? ? (Koenekoop et al., 2002)

AIPL1

LCA-58 (Yzer et al., 2006) Belgium - X E6 c.834G>A* p.Trp278X* E6 c.834G>A p.Trp278X (Sohocki et al., 2000a)

LCA-59 Belgium - NA E6 c.834G>A* p.Trp278X* E6 c.834G>A* p.Trp278X* (Sohocki et al., 2000a)

LCA-60 Belgium NA E6 c.834G>A* p.Trp278X* E6 c.834G>A* p.Trp278X* (Sohocki et al., 2000a)

LCA-61 Belgium - X E6 c.834G>A* p.Trp278X* E6 c.834G>A* p.Trp278X* (Sohocki et al., 2000a)

LCA-62 Africa - in cis E3 c.341C>T* p.Thr114Ile*UV ? ? ? (Sohocki et al., 2000b)
c.1126C>T p.Pro376SerUV

CRX

LCA-63 Belgium SC NA E4 c.425A>G* p.Tyr142Cys* UV ? ? ? (Vallespin et al., 2007a)

LCA-64 Ruanda NA E3 c.724G>A* p.Val242Met* UV ? ? ? (Swain et al., 1997)

RDH12

EORD-6 Belgium - X E6 c.806_810del* p.Ala269GlyfsX2* E8 c.698T>A p.Val233Asp (Janecke et al., 2004), https://www.carverlab.org/carver-mutation-database

EORD-7 Belgium + X E6 c.806_810del* p.Ala269GlyfsX2* E7 c.524C>T p.Ser175Leu (Janecke et al., 2004)

EORD-8 Belgium E6 c.806_810del p.Ala269GlyfsX2 E6 c.806_810del p.Ala269GlyfsX2 (Janecke et al., 2004)

RPGRIP1

LCA-65 Belgium E16 c.2668C>T* p.Arg890X* ? ? ? (Gerber et al., 2001)

Novel mutations are indicated in bold.

+

patients carrying a heterozygous mutation in an additional gene: LCA-3 (AHI1, c.2273A>C, p.His758Pro), LCA-16 (RPE65, c.253C>T, p.Arg85Cys) (Stone, 2007), LCA-20 (CRB1, c.2401A>T, p.Lys801X) (den Hollander et al., 2001) and CORS-1 (AHI1, c.2433T>G, p.Asn81 1Lys).

*

identified through LCA chip analysis.

F

LCA-7 and LCA-25 are distantly related. X: segregation analysis performed and segregation confirmed. NA: no material available of family members. Reference: first publication describing the mutation in patients with LCA or EORD. In case of CEP290, these references may also refer to papers dealing with other phenotypes (phenotype mentioned between brackets). Seven patients were already described (corresponding reference is indicated in the first column).

Abbreviations used: par cons: parental consanguinity; segr: segregation; FC: first cousins; SC: second cousins; TC: third cousins; SD: second degree; ND: no data; UV, unclassified variant; LCA, Leber Congenital Amaurosis; SLS, Senior-Loken syndrome; JS, joubert syndrome; ARRP, autosomal recessive retinitis pigmentosa; CORS, cerebello-oculo-renal syndrome; ML, Meckel-like syndrome.